News

Valide Identifikation von Gütern in explosionsgefährdeten Bereichen

(c) by iDTRONIC GmbH

Raue Umgebungen benötigen robuste und sichere RFID Lösungen. Der Einfluss von Staub, Wasser oder Feuer stellt für viele Geräte eine Herausforderung dar. Die neuen Heavy Duty RFID Tags von iDTRONIC wurden speziell für diese Art von Anwendungen entwickelt. Outdoor-Umgebungen mit Metallen, Chemikalien, hohen Temperaturen oder großen Wassermengen halten die RFID Tags ohne Probleme stand. Die RFID Tags sind ATEX kompatibel und passiv orientiert und zeichnen sich durch eine lange Haltbarkeit aus. Die valide Identifikation der ATEX RFID Tags ist mit jedem beliebigen RFID Reader umsetzbar, der den Standard EPC Global Class1Gen2 ISO/IEC 18000-6C unterstützt.

Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare cancer which has no exact cause but carries various risk factors. Undergoing as radiotherapy to treat other cancer is one of the factors that is increasing the risk of fibrosarcoma. Currently, there are very few ways to treat fibrosarcoma with complications involved. Hence, researchers and research institutes around the world are researching for some very effective treatments. Targeted therapies are also being focused on to treat fibrosarcoma. There are also many anti-angiogenesis agents under development and few are in clinical trials. Chemotherapy for soft tissue sarcoma usually involves a combination of various drugs. Hence, companies are researching on new drugs effective in treating soft tissue sarcoma.

Der Trennungsexperte und Business Coach leitet auf der Münchner Messe einen Intensiv-Workshop mit dem Titel "Job weg - Neu durchstarten!" und hält einen Vortrag zum selben Thema

Everhard Uphoff

Grassau, 09. September 2019 - Everhard Uphoff, Trennungsexperte für Fach- und Führungskräfte, ist auf der diesjährigen job40plus Messe in München vertreten. Die spezielle Jobmesse für erfahrene Arbeitnehmer findet am 26. September 2019 im Konferenzzentrum in der Lazarettstrasse statt. Sie bietet neben individuellen Kurzcoachings und interessanten Vorträgen auch die Möglichkeit, direkt erste Vorstellungsgespräche mit den anwesenden Firmen zu führen.

Im Vorfeld zur Messe bietet der erfahrene Business Coach Uphoff am Vormittag einen mehrstündigen Workshop für frisch gekündigte Arbeitnehmer mit dem Titel "Job weg - Neu durchstarten!" an. Ob gemobbt, diskriminiert oder ein Abschied ohne Dank und Wertschätzung - dies geht nicht spurlos an den Betroffenen vorüber. Wichtig in dieser Situation ist es, die aktuellen Themen aufzuarbeiten, um wieder gestärkt in die Zukunft starten zu können.

von Soeren Janssen - Unterhaltung meets Coaching

"Das Leben klopft an deine Tür" heißt Janssens neues Live-Programm

"Das Leben klopft an deine Tür" heißt das neue Live-Programm von Soeren Janssen

Persönlichkeitsentwicklung und Unterhaltung sind die zentralen Themen im neuen Programm "Das Leben klopft an deine Tür" von Soeren Janssen. Er verbindet Entertainment und Wissensvermittlung auf dem Gebiet der Persönlichkeitsentwicklung und des Life-Coachings. Janssen liefert ein Programm, welches es so noch nie gegeben hat.

Experte für Persönlichkeitsentwicklung bringt unterhaltsames Live-Programm

Sepsis is a severe illness triggered by body’s response to an infection. Factors that are resulting in the growth of sepsis diagnostics market are the rise in aging population, increasing incidences of hospital acquired infections and the growth in the development of innovative products and approvals of those products. Major market players are also increasingly investing in the research and development of new treatments, tests and interventions in order to detect, treat and prevent diseases. Depending on the symptoms, various tests are being performed including blood tests, laboratory tests, and imaging scans. Also, a lot of diagnostic tools are under the approval process and clearance by the Food and Drugs Administration (FDA).

According to a study by Fact.MR, the global sepsis diagnostics market is expected to witness strong growth, registering 7.7% CAGR during the forecast period 2017-2026. The global sepsis diagnostics market is also projected to generate US$ 707.3 million revenue by the end of 2026. Owing to the increase in scope and applications, significant growth is expected in the market. Moreover, early detection has been shown to be crucial for the better outcome of patients suffering from sepsis. Following are the insights on how the global sepsis diagnostics market will perform in the coming years.

With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use and enhanced safety, their demand is expected to increase at a high pace in the coming years.

According to Fact.MR analysis on prefilled syringes, the global market for prefilled syringes is anticipated to expand at a meteoric rate during the period of forecast. The global prefilled syringes market is poised to grow at a volume CAGR of 9.1% during the period of assessment, 2017-2026 and the sale of prefilled syringes across the globe is estimated to cross US$ 11 Bn by end of the year of assessment (2026).

Manufacturers are focused on developing enhanced prefilled syringe systems to cater to the growing demand for these injectable drug delivery systems. For instance, Becton Dickinson has developed PosiFlush prefilled syringes with a 4% sodium citrate lock solution that can reduce the number of catheters for hemodialysis by about exchanged per 1000 days by about 59% thus minimizing risks.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=603

Fiducial markers sales are anticipated to surpass 100 Mn by 2019, registering an upswing from 93.9 Mn in 2018, according to a Fact.MR study. As fiducial markers gain traction in parallel to rising incidences of various cancer forms affecting lung, prostate, abdomen and kidney, the growth potential of the market is set to witness a considerable rise. The escalating demand for fiducial markers can be accredited to,

Growing adoption of radiotherapy devices by oncologists
Surging demand for IGRT and SBRT procedures
Versatility of fiducial markers in effective diagnosis
Increasing rates of cancer across the globe
As per the Fact.MR study, the adoption of fiducial markers for prostate cancer have been witnessing a persistent increase, driven by their ability in terms of seamless target precision. Thus, rising adoption of fiducial markers as an effective tool for use in case of radiation treatment is fostering its popularity.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

Fact.MR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026. According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market. The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.

Increasing preference for self-diagnosis continues to be a trigger for home diagnostics sales, whereas a combination of industry-specific and regulatory factors continue to influence the strategies of market players. Governing bodies such as the U.S. Food and Drug Administration (FDA) and the European Commission regulate home diagnostics with stringent quality control regulations and labeling requirements. Gaining EU CE mark, FDA 510(k) clearance, and FDA approved Premarket Approval Application (PMA) continues to be a primary focus for home diagnostics manufacturers who are looking to scale up their presence in developed markets.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

Worldwide sales of rapid oral fluid screening devices are estimated to surpass 17,700 thousand units in 2019, up from nearly 16,500 units in 2018. The growing demand for of rapid oral fluid screening devices can be attributed to the ever-augmenting cases of drug abuse and alcoholism in many countries across the globe. Tougher regulations and mandates for drug and alcohol testing continue to induce momentum in this market.

The study finds that efficacy of oral fluid for drug testing is being widely acknowledged on account of accuracy and precision of results. Multiple applications, such as pain management, drug treatment, and DUID (driving under influence of drugs) or drug-impaired driving, entail use of rapid oral fluid screening devices for instant yet accurate results. In addition, increasing number of hospital-based laboratories and independent laboratories are making use of rapid oral fluid screening devices to perform multimodal tests.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2694